Skip to main content
Sign in
Sign up
Sign in
Sign up
About
Issues
Editorial Info
Editorial Board
Permissions
Editorial Board Policies
Contributors
Awards and Recognition
Author Guidelines
Poster Presenters Help
Submit a Manuscript
Peer Reviewer Guidelines
Contact
Feedback and Support
Advertising
AAPP
About Psychiatric Pharmacists
About AAPP
AAPP Annual Meeting
Online ACPE Courses
Join AAPP
About
Issues
Editorial Info
Editorial Board
Permissions
Editorial Board Policies
Contributors
Awards and Recognition
Author Guidelines
Poster Presenters Help
Submit a Manuscript
Peer Reviewer Guidelines
Contact
Feedback and Support
Advertising
AAPP
About Psychiatric Pharmacists
About AAPP
AAPP Annual Meeting
Online ACPE Courses
Join AAPP
Issue Info
Issues
Volume 5: Issue 2
Publication Date:
01 Mar 2015
Online ISSN:
2168-9709
Issues
Volume 5: Issue 2
Publication Date:
01 Mar 2015
Online ISSN:
2168-9709
Select Issue
REVIEW OF DRUGS/PHARMACOTHERAPY
Clozapine underutilization in treatment-resistant schizophrenia
Robert J. Stanton II
BS
,
Chris Paxos
PharmD, BCPP, BCPS, CGP
,
Werner J. Geldenhuys
,
B Pharm
PhD
,
Jessica L. Boss
PharmD, BCPS, CGP
,
Mark Munetz
MD
,
Altaf S. Darvesh
, and
M Pharm
PhD
DOI:
10.9740/mhc.2015.03.063
Abstract
Download PDF
A review of the clinical utility of serum clozapine and norclozapine levels
Justin C. Ellison
PharmD
and
Robert L. Dufresne
PhD, PhD, BCPS, BCPP
DOI:
10.9740/mhc.2015.03.068
Abstract
Download PDF
LITERATURE REVIEW
Indicators of response to clozapine treatment
Dongmi Kim
PharmD, BCPS, BCPP
DOI:
10.9740/mhc.2015.03.074
Abstract
Download PDF
ORIGINAL RESEARCH
Pharmacogenomics of lamotrigine: a possible link to serious cutaneous adverse reactions
Rebecca Campbell
PharmD
and
Jennifer Beall
PharmD, BCPS
DOI:
10.9740/mhc.2015.03.078
Abstract
Download PDF
CASE REPORT
Clozapine-induced myocarditis may warrant cardiac monitoring protocol
Lacey J. Miller
PharmD
and
Rachel E. Grande
PharmD
DOI:
10.9740/mhc.2015.03.082
Abstract
Download PDF
Successful clozapine rechallenge following clozapine-induced neuroleptic malignant syndrome
Clint Ross
PharmD, BCPP
DOI:
10.9740/mhc.2015.03.088
Abstract
Download PDF
Get Email Alerts
Get eTOC Alerts
Get Ahead of Print Alerts
Managing ciprofloxacin-clozapine interaction with immunoassay-based monitoring: A case report
Kristin Waters
PharmD, BCPS, BCPP
,
Victoria Popielarz
BS, PharmD Candidate
,
Joseph Lumasag
BS, PharmD Candidate
,
Sara Wiesenfeld
BS, PharmD Candidate
, and
Ashley Tewksbury
PharmD, BCPP
Impact of psychiatric pharmacist-led ambulatory alcohol withdrawal management
Maxwell Lamb
PharmD, BCPS
,
Michelle Colvard
PharmD, BCPP
,
Jonathan Lister
PharmD, BCPP
, and
Eric Johnson
PharmD, BCPP
Management of antidepressant-induced bruxism
Hayley Cliatt
PharmD
,
Andrew M. Williams
PharmD, BCPP
, and
Jessa Koch
PharmD, BCPP
Evaluating the efficacy of blister packaging in improving medication adherence within psychiatry: A systematic literature review
Eric P. Borrelli
PhD, PharmD, MBA
,
Monica Telinoiu
MS, MBA
,
Peter Saad
PharmD, MBA
,
Nathan Barnes
PharmD, MHA
,
Heather Nelkin
PharmD, MBA
, and
Julia D. Lucaci
PharmD, MS
Evaluation of burnout among Board-Certified Psychiatric Pharmacists in the United States
Samantha Catanzano
PharmD, BCPP
,
Jennifer N. Gemmellaro
PharmD, BCPP, BCPS
,
Melissa Mooers Gross
BS, PharmD, MHA, BCPP, BCPS, BCGP, BCIDP, CPEL, CPPS
,
Monica Fahmy
PharmD, BCPP, BCPS
,
Gregory H. Payne
MBA, CAE
, and
Kelly C. Lee
PharmD, MAS, BCPP, FCCP
About
Issues
Advertising
Permissions
Facebook
X
LinkedIn
eISSN
: 2168-9709
Powered by
PubFactory